Savara added to russell 3000® index

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has been added to the u.s. broad-market russell 3000® index at the conclusion of the russell indexes annual reconstitution, effective upon the u.s. market open on monday, june 26, 2023. annual russell indexes reconstitution captures the 4,000 largest u.s. stocks as of april 28, ranking them by total market capitalization. membership.
SVRA Ratings Summary
SVRA Quant Ranking